SCHEMBL2109239

SCHEMBL2109239

CN(C)/N=N\c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
TDP1 Q9NUW8 3/20 0.54
MAPK1 P28482 2/20 0.54
TSHR P16473 2/20 0.54
HSD17B10 Q99714 1/20 0.54
LMNA P02545 1/20 0.50
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
MAPT P10636 5/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
PKM P14618 3/20 0.42
HTT P42858 1/20 0.42
TNNI3 P19429 1/20 0.42
TNNT2 P45379 1/20 0.42
TNNC1 P63316 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EGFR P00533 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187587 1.00 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL2109241 1.00 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL8619130 0.87 LMNA (0.55) ALDH1A1TDP1MAPK1TSHRHSD17B10
Isothiocyanate SCHEMBL9197203 0.87 TDP1 (0.44) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL9753362 0.87 LMNA (0.55) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL2474219 0.86 LMNA (0.61) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL2474220 0.86 LMNA (0.61) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL2472953 0.82 MAPT (0.46) ALDH1A1TDP1MAPK1TSHRHSD17B10
SCHEMBL2472954 0.82 MAPT (0.46) ALDH1A1TDP1MAPK1TSHRHSD17B10
Azobenzene SCHEMBL1405620 0.80 ALDH1A1 (0.75) ALDH1A1TDP1MAPK1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130850-A1 TISSUE TARGETING BY MEANS OF ONCOCIDAL BRIDGED DIPHENYL DERIVATIVES FOR THE SELECTIVE TREATMENT OF SEXUAL ORGAN TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-04 WO disclosed
US-8158685-B2 Method for bone growth STEINER GREGORY GENE (US) 2012-04-17 US disclosed
WO-2007011575-A2 METHOD AND COMPOSITION FOR BONE GROWTH STEINER GREGORY (US) 2007-01-25 WO disclosed
US-20060008502-A1 Method and composition for bone growth STEINER GREGORY G 2006-01-12 US disclosed
US-20030170318-A1 Fluoride compositions and uses thereof STEINER HEALTHCARE LLC 2003-09-11 US disclosed
US-20020041902-A1 Fluoride as a chemoprotective and chemotheraputic agent for cancer in mammals STEINER GREGORY GENE (US) 2002-04-11 US disclosed
WO-2002028401-A1 FLUORIDE AS A CHEMOPROTECTIVE AND CHEMOTHERAPEUTIC AGENT FOR CANCER IN MAMMALS STEINER GREGORY (US) 2002-04-11 WO disclosed